Global preimplantation genetic testing market is anticipated to grow at a significant CAGR of 11.9% during the forecast period (2024-2031).A major factor supporting the growth of the market is the increasing prevalence of genetic disorders and chromosomal abnormalities. As awareness of these conditions grows and technological advancements in genetic testing improve, more individuals and couples are turning to preimplantation genetic testing as a means to identify and mitigate the risk of passing on genetic conditions to their offspring. To meet the demand for advanced testing kit among end-user, in 2023, Thermo Fisher Scientific Inc. introduced two novel Next-Generation Sequencing (NGS)-based test kits tailored to bolster preimplantation genetic testing-aneuploidy (PGT-A). This advancement represents a significant contribution to the realm of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) research, aiming to enhance the accuracy and efficiency of genetic screening processes.
Browse the full report description of “Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report by ProcedureType (Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis), by Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Comparative Genomic Hybridization and Single-Nucleotide Polymorphism), by Product (Reagents and Consumables, Instruments and Software and Services) by Application (Aneuploidy, Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing and Gender Identification) and by End-User (Fertility Clinics, Hospitals and Diagnostic Laboratories) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/preimplantation-genetic-testing-market
Further, in February 2022, The Cooper Companies, Inc.unveiled a notable expansion to their PGT-A testing framework. This enhancement, branded as PGT-Complete, encompasses the integration of Parental QC, Genetic PN check, and Origin of Aneuploidy components. Such additions signify a comprehensive approach towards PGT-A testing, elevating standards in genetic analysis within the context of IVF procedures.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Procedure Type
o By Technology
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includesF. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp, Agilent Technologies, Inc., Invicta Genetics and others.
Key questions addressed by the report.
Global Preimplantation Genetic Testing Market Report Segment
By Procedure Type
By Technology
By Product
By Application
By End-User
Global Preimplantation Genetic Testing Market Report Segment byRegion
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/preimplantation-genetic-testing-market